Emerging Stocks Down Under 12 April 2022: EBR Systems (ASX:EBR)

EBR Systems: Will it win investor’s hearts?

EBR Systems (ASX: EBR) is another heart disease focused medtech that listed on the ASX late last year. The company’s WISE system works as a pacemaker, delivering pacing stimulation directly to the left ventricle of the heart thereby preventing heart failure. It is the size of a cooked grain of rise – 5% the size of a conventional pacemaker – and is currently in a pivotal trial, with FDA approval hoped for next year. This stock is one to watch but we would rather last week’s subject Artrya (ASX: ATA) at this stage considering its earlier timeline for FDA approval.

Click here to read the previous edition of Emerging Stocks Down Under published 5 April 2022

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.